This association becomes statistically significant when we compare patient survival five years after initial diagnosis ( P =0.03), suggesting a notable trend of poor long-term survival in patients with lower PREX1 methylation.
← all excerpts
Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
1
—
—